» Articles » PMID: 23747863

Creation of a Suppressive Microenvironment by Macrophages and Cancer-associated Fibroblasts

Overview
Specialty Biology
Date 2013 Jun 11
PMID 23747863
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The cancer microenvironment makes up the stroma of the neoplasm and is the tissue that determines tumor growth, progression, and ability to initiate metastases. Because of the role that the cancer microenvironment plays in each stage of tumor development, knowledge about the interactions of the tumor with its microenvironment would seem to be of the utmost importance for developing new treatment strategies. The cancer microenvironment is created by the tissue surrounding the tumor cells and is composed of cells, extracellular matrix, and the proteins of the extracellular matrix. Although tumor cells are capable of penetrating the surrounding stroma, it is the tumor stroma that provides the necessary blood supply and growth factors for the tumor cells that condition tumor growth. In the present review we discuss the role of various cells like tumor-associated macrophages and cancer-associated fibroblasts, expressing RCAS1, B7-H4 molecules, and MT in creating the suppressive profile of the cancer microenvironment and in the cancer microenvironment remodeling that enables both local tumor spread and the creation of metastases.

Citing Articles

The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.

Asiry S, Kim G, Filippou P, Sanchez L, Entenberg D, Marks D Front Immunol. 2021; 12:654877.

PMID: 33927723 PMC: 8076861. DOI: 10.3389/fimmu.2021.654877.


Depleting Tumor Cells Expressing Immune Checkpoint Ligands-A New Approach to Combat Cancer.

Marcucci F, Rumio C Cells. 2021; 10(4).

PMID: 33921301 PMC: 8069236. DOI: 10.3390/cells10040872.


The analysis of Treg lymphocyte blood percentage changes in patients with head and neck cancer during combined oncological treatment: a preliminary report.

Dutsch-Wicherek M, Chaberek K, Makarewicz A, Antoni S I, Witwicki J, Bielecki I Cent Eur J Immunol. 2021; 45(4):409-413.

PMID: 33658889 PMC: 7882406. DOI: 10.5114/ceji.2020.103417.


Harnessing the heart's resistance to malignant tumors: cardiac-derived extracellular vesicles decrease fibrosarcoma growth and leukemia-related mortality in rodents.

Grigorian-Shamagian L, Fereydooni S, Liu W, Echavez A, Marban E Oncotarget. 2017; 8(59):99624-99636.

PMID: 29245929 PMC: 5725120. DOI: 10.18632/oncotarget.20454.


Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.

Jozwicki W, Brozyna A, Siekiera J, Slominski A Oncotarget. 2016; 7(10):11450-62.

PMID: 26862849 PMC: 4905485. DOI: 10.18632/oncotarget.7199.